Publication Name	World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID	19049
Country	United Kingdom

Received	2015-04-29 21:51
Peer-Review Started	2015-05-07 09:51
To Make the First Decision	2015-09-14 17:40
Return for Revision	2015-09-15 14:33
Revised	2015-10-06 22:32
Second Decision	2015-11-02 14:39
Accepted by Journal Editor-in-Chief	2015-11-05 23:10
Accepted by Executive Editor-in-Chief	2015-11-11 18:12
Articles in Press	2015-11-11 18:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-17 18:39
Publish the Manuscript Online	2016-01-29 11:06

ISSN	2150-5349 (online)
Open Access	Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease
Manuscript Source	Invited Manuscript
All Author List	Anet A Soubières and Andrew Poullis
Funding Agency and Grant Number
Corresponding Author	Dr. Anet A Soubières, Department of Gastroenterology, St George’s Hospital, University of London, Blackshaw Road, Tooting, London SW17 0QT, United Kingdom. anet.soubieres@gmail.com
Key Words	Biomarkers; Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Indeterminate colitis
Core Tip	There is no gold standard test in the diagnosis of inflammatory bowel disease (IBD). Physicians must take into account clinical, endoscopic, and radiologic as well as serologic and histologic evidence in order to correctly diagnose their patients. Endoscopic evaluation is not only expensive, but is uncomfortable for patients and not without significant risk such as perforation. The use of biomarkers to help in the diagnosis and sub classification of IBD is an expanding area. In this review we touch on those non-invasive markers currently in clinical use before focusing on those more novel tests, with the potential to be highly useful in both diagnosis and differentiation of IBD.
Publish Date	2016-01-29 11:06
Citation	Soubières AA, Poullis A. Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7(1): 41-50
URL	http://www.wjgnet.com/2150-5349/full/v7/i1/41.htm
DOI	http://dx.doi.org/10.4292/wjgpt.v7.i1.41

Full Article (PDF)	WJGPT-7-41.pdf
Full Article (Word)	WJGPT-7-41.doc
Manuscript File	19049-Review.docx
Answering Reviewers	19049-Answering reviewers.pdf
Audio Core Tip	19049-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	19049-Conflict-of-interest statement.pdf
Copyright License Agreement	19049-Copyright assignment.pdf
Peer-review Report	19049-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	19049-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	19049-Scientific misconduct check.pdf
Scientific Editor Work List	19049-Scientific editor work list.pdf